Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations
Aim: To evaluate the availability of published comparative real-world evidence (RWE) studies in Medicare patients for the ten drugs set to undergo Centers for Medicare and Medicaid Services (CMS) price negotiations in 2026. Materials & methods: A scoping review was completed in MEDLINE/PubMed to...
Saved in:
Main Authors: | Ashley Jaksa (Author), Patrick J Arena (Author), Nicolle Gatto (Author) |
---|---|
Format: | Book |
Published: |
Becaris Publishing Limited,
2023-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016-2019 data
by: Omar Qureshi, et al.
Published: (2024) -
The Center for Medicare and Medicaid Innovation: The Case for Reform
by: Doug Badger MDiv
Published: (2022) -
Effects of Diagnosed Dementia on Medicare and Medicaid Program Costs
by: Padmaja Ayyagari, et al.
Published: (2007) -
How Do the Hospital Prices Paid by Medicare Advantage Plans and Commercial Plans Compare With Medicare Fee-for-Service Prices?
by: Jared Lane K. Maeda PhD, MPH, et al.
Published: (2018) -
The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology
by: Charles E. Leonard, et al.
Published: (2017)